Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
RACA THERAPEUTICS ACQUISITION CORP
0.0000.0000.00%
YOY
Do not show
Hide blank lines
(Q1)2021/03/31(Q4)2020/12/31(Q3)2020/09/30(Q2)2020/06/30
Total revenue
0 0 0 0
Operating revenue
-- 0 -- 0 -- 0 -- 0
Cost of revenue
Gross profit
Operating expense
1.4M 130.23K 168.31K 19.37K
Selling and administrative expenses
-- 1.4M -- 130.23K -- 168.31K -- 19.37K
-General and administrative expense
-- 1.4M -- 130.23K -- 168.31K -- 19.37K
Operating profit
-1.4M -130.23K -168.31K -19.37K
Net non-operating interest income expense
3.35K 3.42K 2.97K
Non-operating interest income
-- 3.35K -- 3.42K -- 2.97K -- --
Other net income (expense)
Income before tax
-1.4M -126.81K -165.34K -19.37K
Income tax
Net income
-1.4M -126.81K -165.34K -19.37K
Net income continuous Operations
-- -1.4M -- -126.81K -- -165.34K -- -19.37K
Minority interest income
Net income attributable to the parent company
-1.4M -126.81K -165.34K -19.37K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-1.4M -126.81K -165.34K -19.37K
Basic earnings per share
-0.3621 -0.033 -0.0434 -0.0015
Diluted earnings per share
-0.3621 -0.033 -0.0434 -0.0015
Dividend per share
Currency Unit
USDUSDUSDUSD

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
CEO: --
Market: --
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist